OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
238200$2840.0058

Bifido Co Ltd

Food ProcessingVerified

Bifido Co Ltd's capital structure is characterized by a debt-to-equity ratio of 0.27, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a current ratio of 2.55, suggesting it can cover its short-term obligations. However, the company's cash and equivalents are negative at -370 KRW, and its free cash flow is negative at -5.48 billion KRW, indicating a cash outflow from operations after capital expenditures. Profitability metrics show a mixed picture. The company reported a net loss of 192.74 million KRW and an operating income of 1.4 billion KRW. Return on equity (ROE) is negative at -0.42%, and return on assets (ROA) is also negative at -0.31%. These figures are below the industry median for ROE and ROA, which are typically positive for companies in the Food Processing industry. The company's revenue is primarily concentrated in its domestic and overseas markets, with no specific segment breakdown provided. The lack of detailed segment data limits the ability to assess geographic exposure and revenue concentration. However, the company's operations span multiple product lines, including functional health foods, pet feed, and cosmetics. Looking at the growth trajectory, the company's revenue is expected to increase from 19.68 billion KRW to 33.9 billion KRW, representing a significant growth rate. Analyst estimates suggest a mean revenue estimate of 33.9 billion KRW, with a mean EBIT estimate of 10.1 billion KRW. This indicates a potential improvement in profitability and operational efficiency. Risk factors include a negative net cash position and a negative free cash flow, which could impact the company's ability to fund operations and investments. The company's dilution risk is assessed as low, with no significant dilution potential identified. However, the negative free cash flow and capital expenditures of -7.24 billion KRW suggest the company may need to seek additional financing in the near term. Recent events include the publication of the latest financial snapshot and analyst estimates. The company's financial performance and outlook are being closely monitored by analysts, with expectations for improved revenue and EBIT in the upcoming fiscal year.

30-day price · 238200+110.00 (+3.9%)
Low$2600.00High$3265.00Close$2935.00As of21 May, 00:00 UTC
Profile
CompanyBifido Co Ltd
Ticker238200.KQ
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. Bifido Co Ltd is a Korea-based company engaged in the manufacture and sale of functional health foods, including probiotic raw materials and finished products based on bifidobacteria, supplementary feed for pets, and cosmetics such as creams and serums.

Classification. Bifido Co Ltd is classified under the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Food Processing industry with a confidence level of 0.92.

Bifido Co Ltd's capital structure is characterized by a debt-to-equity ratio of 0.27, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a current ratio of 2.55, suggesting it can cover its short-term obligations. However, the company's cash and equivalents are negative at -370 KRW, and its free cash flow is negative at -5.48 billion KRW, indicating a cash outflow from operations after capital expenditures. Profitability metrics show a mixed picture. The company reported a net loss of 192.74 million KRW and an operating income of 1.4 billion KRW. Return on equity (ROE) is negative at -0.42%, and return on assets (ROA) is also negative at -0.31%. These figures are below the industry median for ROE and ROA, which are typically positive for companies in the Food Processing industry. The company's revenue is primarily concentrated in its domestic and overseas markets, with no specific segment breakdown provided. The lack of detailed segment data limits the ability to assess geographic exposure and revenue concentration. However, the company's operations span multiple product lines, including functional health foods, pet feed, and cosmetics. Looking at the growth trajectory, the company's revenue is expected to increase from 19.68 billion KRW to 33.9 billion KRW, representing a significant growth rate. Analyst estimates suggest a mean revenue estimate of 33.9 billion KRW, with a mean EBIT estimate of 10.1 billion KRW. This indicates a potential improvement in profitability and operational efficiency. Risk factors include a negative net cash position and a negative free cash flow, which could impact the company's ability to fund operations and investments. The company's dilution risk is assessed as low, with no significant dilution potential identified. However, the negative free cash flow and capital expenditures of -7.24 billion KRW suggest the company may need to seek additional financing in the near term. Recent events include the publication of the latest financial snapshot and analyst estimates. The company's financial performance and outlook are being closely monitored by analysts, with expectations for improved revenue and EBIT in the upcoming fiscal year.
Key takeaways
  • Bifido Co Ltd has a conservative debt-to-equity ratio of 0.27, indicating a relatively low leverage position.
  • The company reported a net loss of 192.74 million KRW and a negative ROE of -0.42%, which are below industry medians.
  • Analysts expect a significant increase in revenue to 33.9 billion KRW, with a mean EBIT estimate of 10.1 billion KRW.
  • The company's liquidity is assessed as medium, with a current ratio of 2.55, but it has a negative cash and equivalents position.
  • The company's risk assessment highlights a negative net cash position and a negative free cash flow, which could impact its financial stability.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$19.68B
Gross profit$7.49B
Operating income$1.40B
Net income-$192.7M
R&D
SG&A
D&A
SBC
Operating cash flow$3.95B
CapEx-$7.24B
Free cash flow-$5.48B
Total assets$61.30B
Total liabilities$15.37B
Total equity$45.93B
Cash & equivalents-$370.00
Long-term debt$12.25B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$19.68B$1.40B-$192.7M-$5.48B
FY-1$12.35B-$5.04B-$5.40B-$9.58B
FY-2$18.63B-$343.7M$1.08B-$383.6M
FY-3$14.58B$1.26B$1.55B$2.18B
FY-4$12.12B-$1.07B$4.49B-$8.47B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$61.30B$45.93B-$370.00
FY-1$61.21B$46.69B$200.00
FY-2$71.74B$51.70B$120.00
FY-3$54.94B$52.49B$160.00
FY-4$54.65B$50.64B-$430.00
PeriodOCFCapExFCFSBC
FY0$3.95B-$7.24B-$5.48B
FY-1-$716.3M-$6.12B-$9.58B
FY-2$2.85B-$3.34B-$383.6M
FY-3$1.88B-$1.10B$2.18B
FY-4$2.04B-$14.71B-$8.47B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$4.83B$359.6M-$914.0M-$1.39B
FQ-1$3.71B-$375.0M-$222.8M-$1.98B
FQ-2$6.20B$1.34B$757.8M-$890.9M
FQ-3$4.95B$79.4M$186.2M-$1.22B
FQ-4$3.80B-$835.1M-$968.0M-$3.51B
FQ-5$2.36B-$1.56B-$1.61B-$2.57B
FQ-6$3.02B-$1.75B-$1.74B-$1.96B
FQ-7$3.17B-$902.2M-$1.08B-$1.53B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$61.30B$45.93B-$370.00
FQ-1$64.43B$47.49B-$380.00
FQ-2$63.83B$47.66B$190.00
FQ-3$63.17B$46.92B$190.00
FQ-4$61.21B$46.69B$200.00
FQ-5$60.95B$47.54B$310.00
FQ-6$69.85B$49.09B-$480.00
FQ-7$70.87B$50.76B-$390.00
PeriodOCFCapExFCFSBC
FQ0$3.95B-$7.24B-$1.39B
FQ-1$3.38B-$6.30B-$1.98B
FQ-2$3.23B-$4.04B-$890.9M
FQ-3$1.18B-$1.90B-$1.22B
FQ-4-$716.3M-$6.12B-$3.51B
FQ-5-$1.20B-$3.09B-$2.57B
FQ-6-$4.69B-$1.63B-$1.96B
FQ-7$67.2M-$924.2M-$1.53B
Valuation
Market price$2840.00
Market cap$23.23B
Enterprise value$35.48B
P/E
Reported non-GAAP P/E
EV/Revenue1.8
EV/Op income25.3
EV/OCF9.0
P/B0.5
P/Tangible book0.5
Tangible book$45.93B
Net cash-$12.25B
Current ratio2.5
Debt/Equity0.3
ROA-0.3%
ROE-0.4%
Cash conversion-20.5%
CapEx/Revenue-36.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food Processing · cohort 6 companies
Metric238200Activity
Op margin7.1%3.3% medp25 2.5% · p75 4.5%top quartile
Net margin-1.0%3.0% medp25 1.5% · p75 6.7%bottom quartile
Gross margin38.1%24.0% medp25 20.2% · p75 35.3%top quartile
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue-36.8%5.2% medp25 4.8% · p75 5.7%bottom quartile
Debt / equity27.0%33.5% medp25 29.1% · p75 81.5%bottom quartile
Observations
IR observations
Last actual EPS193.50 KRW
Mean revenue estimate33,900,000,000 KRW
Mean EBIT estimate10,100,000,000 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-02 03:25 UTC#5bd94066
Market quoteclose KRW 2840.00 · shares 0.01B diluted
no public URL
2026-05-02 03:25 UTC#e9ed12a6
Source: analysis-pipeline (hybrid)Generated: 2026-05-02 03:26 UTCJob: 412b5c27